Tag: Bio-Rad stock performance
Bio-Rad FY24 Revenue Forecast: Non-GAAP Revenue Expected to Decline 2.5%-4%
Bio-Rad, a global leader in life science research and clinical diagnostics, has recently announced its revenue forecast for the fiscal year 2024. According to...